HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jiatong Ji Selected Research

Drug Administration Schedule

12/2021Dynamics of Acquired Resistance to Nivolumab Therapies Varies From Administration Strategies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jiatong Ji Research Topics

Disease

1Neoplasms (Cancer)
12/2021

Drug/Important Bio-Agent (IBA)

1NivolumabIBA
12/2021
1Pharmaceutical PreparationsIBA
12/2021
1Janus KinasesIBA
12/2021

Therapy/Procedure

1Drug Administration Schedule
12/2021